Skip-Lot Testing and the FDA - Reduced Testing Plan for Raw Materials

C

ConnieH

#1
I need help! :confused:

I'm trying to establish a reduced testing plan for raw materials involved in the production of API (Active Pharmaceutical Ingredients).

I've done some online research and have tracked down some possibilities. The term skip-lot testing keeps popping up but I can't seem to determine if it's a viable option as far as the FDA is concerned.

I'm also confused as to whether our current sampling plan (square root of N+1) can be used with skip-lot testing.

I'd really appreciate any help anyone would be able to offer.
 
Elsmar Forum Sponsor
D

Dave Strouse

#3
ASQ Booklet

Connie -

ANSI-ASQ S1-1996 entitled An Attribute Skip-Lot Sampling Program is another reference you may find useful.

I think you are already in some jeopardy with your square root of N+1 plans. I have not been involved foir soem years but CFR-21 used to say "Sampling plans, if used, will be statistically based"

Square root of N+1 sure sounds ad hoc to me. Do you have any kind of statistical rationale written?

Good Luck -
 

CarolX

Super Moderator
Super Moderator
#4
or try this

You can get a copy of MIL-STD-105 here


This was the Department of Defense standard on Attribute Sampling and has instructions for skip lot inspection. The FDA use to accept sampling plans to this standard, but that was 10 years or so ago.

Go to the DOD Index of Specifications and Standards page and type in MIL-STD-105 in the field for the DODISS ID Number. You will need Adobe Acrobat Reader to view it.

CarolX
 
A

Aaron Lupo

#5
Re: Skip-lot testing and the FDA

ConnieH said:

I need help! :confused:

I'm trying to establish a reduced testing plan for raw materials involved in the production of API (Active Pharmaceutical Ingredients).

I've done some online research and have tracked down some possibilities. The term skip-lot testing keeps popping up but I can't seem to determine if it's a viable option as far as the FDA is concerned.

I'm also confused as to whether our current sampling plan (square root of N+1) can be used with skip-lot testing.

I'd really appreciate any help anyone would be able to offer.
It depends on a lot of factors:

1) How many pieces per lot?
2) What is the risk, i.e.. sterile vs., nonsterile product?
3) What does the customer require
4) What is the past performance? Is it a stable process? how many have been rejected in the past?
5) What is the recall process?
 
A

Al Dyer

#6
Very true ISO GUY,

And I think the most importand aspect would be the function of the final product.

If a company is making steel blocks with a tol of +/- 1" as opposed to a substance/drug that could kill somebody, it needs to be taken into account. In past experience this can be documented on a FMEA study. Although some people disagree, FMEA is a tool for all processes, not just automotive.

Al...:bigwave:
 

v9991

Trusted Information Resource
#7
Re: Skip-lot testing and the FDA

Guess, you might have already found suitable references .... just to close the loop for FDA references... further, my interpretation is that if its discussed in the context of human/veterinary drugs then, its certainly relevant for devices as well!

as Aaron has indicated, the protocol depends on comprehensive evaluation product specific requirement. System & Process has to demonstrate superior control on meeting the system requirements.

(system - define a criteria for identifying & evaluating the feasibility of skip testing, define the roll back procedure, further, it has to closely monitor the implementation )
(process - capability - consistency - predictability )

http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm134966.htm
http://www.fda.gov/downloads/Animal...Enforcement/GuidanceforIndustry/UCM052487.pdf

2.1 Periodic or Skip Testing
Periodic or skip testing is the performance of specified tests at release on preselected batches and/or at predetermined intervals, rather than on a batch-by-batch basis, with the understanding that those batches not being tested still meet all acceptance criteria established for that product. This represents a less than full schedule of testing and should therefore be justified and presented to and approved by the regulatory authority prior to implementation. This concept may be applicable to, for example, residual solvents and microbiological testing for solid oral dosage forms. It is recognized that only limited data may be available at the time of submission of an application (see section 2.5). This concept should therefore generally be implemented postapproval. When tested, any failure to meet acceptance criteria established for the periodic test should be handled by proper notification of the appropriate regulatory authority(ies). If these data demonstrate a need to restore routine testing, then batch-
by-batch release testing should be reinstated.
 

v9991

Trusted Information Resource
#8
heres another reference but this one too is for herbal products (not a human drug products)
http://www.ema.europa.eu/docs/en_GB/...C500003393.pdf
2.4. Periodic/skip testing
Periodic or skip testing is the performance of specified tests at release on pre-selected batches and/or at
predetermined intervals, rather than on a batch-to-batch basis. This represents a less than full schedule of
testing and should therefore be justified and presented to the regulatory authority prior to implementation.
This concept may be applicable to, for example, dissolution, residual solvents, and microbiological
testing, e.g., for solid oral dosage forms. This concept may therefore sometimes be implemented postapproval
in accordance with GMP and approval by the Regulatory Authority.
 
#9
Re: Skip-lot testing and the FDA



It depends on a lot of factors:

1) How many pieces per lot?
2) What is the risk, i.e.. sterile vs., nonsterile product?
3) What does the customer require
4) What is the past performance? Is it a stable process? how many have been rejected in the past?
5) What is the recall process?

Do you know some example of skip test plan or where I can find it? Which kind of method I could use to decide if I could reduce the number of test for that raw materiel in coming?
 
Thread starter Similar threads Forum Replies Date
A C=0 and Skip Lot Sampling Plan Relationship Inspection, Prints (Drawings), Testing, Sampling and Related Topics 6
T Skip Lot Sampling Plans (SkSP) - Oil for Trans Fatty Acid Content Inspection, Prints (Drawings), Testing, Sampling and Related Topics 6
M Standards Australia - AS1199.3 2003 Skip Lot inspection Criteria and Requirements Inspection, Prints (Drawings), Testing, Sampling and Related Topics 3
P Skip Lot for product or for Supplier ? Inspection, Prints (Drawings), Testing, Sampling and Related Topics 5
J ANSI/ASQ Z1.4-2003 Sampling with Skip Lot Inspection, Prints (Drawings), Testing, Sampling and Related Topics 2
J Incoming Inspection Skip Lot - Industrial staples Inspection, Prints (Drawings), Testing, Sampling and Related Topics 9
T ISO 2859-3 - Skip-lot sampling procedures - Unauthorized Inspection Frequency Inspection, Prints (Drawings), Testing, Sampling and Related Topics 3
C Sampling - Skip Lot - 20 ppm - What is your opinion of Skip Lot sampling? Inspection, Prints (Drawings), Testing, Sampling and Related Topics 6
A Skip Lot Inspection - What do we look at and when? Inspection, Prints (Drawings), Testing, Sampling and Related Topics 3
M Skip Lot Sampling - How to Perform Skip-Lot and Chain Sampling Inspection, Prints (Drawings), Testing, Sampling and Related Topics 9
J Can I skip Payment Process audit for TS16949 Internal Audit? IATF 16949 - Automotive Quality Systems Standard 4
V Skip Testing for Uniformity of Dosage Units & Dissolution US Food and Drug Administration (FDA) 2
O PPAP Material and Performance Testing - Possible to skip? APQP and PPAP 3
shimonv Single lot release for sterile packaging 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 3
J Sample size definition in an Automotive SMT pilot lot run Misc. Quality Assurance and Business Systems Related Topics 1
Q LOT or Serial Number Symbol not used when the information is contained in the UDI? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 1
D Supplied Product on Control Plan - Lot ranging in 40,000 pcs per product FMEA and Control Plans 3
Z Do we still have to put UDI if we have DI and lot number seperately on our product ? 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 4
K FDA Lot Code format requirements Other Medical Device and Orthopedic Related Topics 1
R Documenting Expiration Date Extension for a specific lot ISO 13485:2016 - Medical Device Quality Management Systems 12
S Lot assignment for secondary reference standard - Pharmaceuticals Manufacturing and Related Processes 0
N AS9100 8.5.1 j) - Lot splitting - any loopholes? AS9100, IAQG, NADCAP and Aerospace related Standards and Requirements 11
S Is Lot Number required in addition to UDI serial number? Other Medical Device Regulations World-Wide 7
I Lot or Batch definition for IVDs Imported Legacy Blogs 0
N IVD Lot Numbers and Expiration Dates - 21 CFR 809.10 Other US Medical Device Regulations 3
J PMA Device - Lot # change in New ERP Software - What are the FDA Requirements 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 0
S Requirements relating to Serial Number and Lot Number Other US Medical Device Regulations 6
V 'Representative' Sample of the Lot for a Continuous Process Inspection, Prints (Drawings), Testing, Sampling and Related Topics 4
J Change in Lot Release Specifications - Definition of "Substantial Change" EU Medical Device Regulations 14
M Lot Numbers of Plastic Disposables in an LDT (laboratory developed test) ISO 13485:2016 - Medical Device Quality Management Systems 6
M How to Mathemetically Derive the AQL Tables given Lot Sizes AQL - Acceptable Quality Level 5
M Component Lot Number Traceability - Class I reusable and "resposable" Medical Devices ISO 13485:2016 - Medical Device Quality Management Systems 10
D Dual Lot Manufacturing requirements for Clinical Customers Manufacturing and Related Processes 3
R Why the FDA requests Lot Number in Testing Reports 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 7
E Is Design Transfer to Production be complete prior to Release of first production lot 21 CFR Part 820 - US FDA Quality System Regulations (QSR) 2
G Validating a Process Based on Lot Release Criteria Inspection, Prints (Drawings), Testing, Sampling and Related Topics 3
U AQL, Lot Size vs Sampling Plans AQL - Acceptable Quality Level 8
Sam Lazzara Lot Release Testing versus Process Validation Studies Qualification and Validation (including 21 CFR Part 11) 9
V FDA regulatory requirement on the lot number convention for medical devices US Food and Drug Administration (FDA) 2
K Can I use ANSI/AQL for the Total Number of Containers for the entire Lot? Inspection, Prints (Drawings), Testing, Sampling and Related Topics 1
H How to calculate the Lot Reject Rate Inspection, Prints (Drawings), Testing, Sampling and Related Topics 4
A How can a sample can give information about bad products in whole lot? Quality Manager and Management Related Issues 3
M Pipet tips of the same Lot Number have different expiration dates Quality Manager and Management Related Issues 6
L Regulatory Submittal During 3 Lot Sterilization Validation EU Medical Device Regulations 1
C Statistics equation to determine the number of samples in a lot Statistical Analysis Tools, Techniques and SPC 8
P Lot Acceptance Plan that specifies BS 6001 Double Sampling Plans, general inspection Inspection, Prints (Drawings), Testing, Sampling and Related Topics 1
K Class Ins CE Mark Labeling Requirements (particularly Lot or Batch symbol and number) EU Medical Device Regulations 7
N Switch to 100% inspection when lot fails sampling? Inspection, Prints (Drawings), Testing, Sampling and Related Topics 9
G Calculating the Fraction Defective Confidence Interval for a Lot Statistical Analysis Tools, Techniques and SPC 2
S Samples for a Destructive Test included in a Lot Size? Inspection, Prints (Drawings), Testing, Sampling and Related Topics 5

Similar threads

Top Bottom